GlassScriptPhysician profile
Debbie A Thomas
NPI 1891912382
$2,683.42
in general payments reported to CMS, 2019-2025
19 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $604 · 2022: $501 · 2023: $703 · 2024: $509 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,285 · Travel and Lodging: $193 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,284.73 |
| Travel and Lodging | $193.06 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $672.27 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Novartis Pharmaceuticals Corporation | $497.49 | 2021-2025 | |
| Csl Behring | $314.61 | 2021-2025 | Afstyla, Idelvion |
| Janssen Biotech, INC. | $204.52 | 2023-2025 | Erleada, Akeega, Balversa |
| Intuitive Surgical, INC. | $193.06 | 2024 | |
| Aveo Pharmaceuticals, INC. | $184.77 | 2021-2024 | Fotivda |
| Bayer Healthcare Pharmaceuticals INC. | $124.15 | 2021-2023 | |
| Genentech USA, INC. | $86.01 | 2023-2025 | Venclexta, Tecentriq |
| Acrotech Biopharma INC. | $75.35 | 2021-2022 | |
| Abbvie INC. | $70.02 | 2025 | |
| Dendreon Pharmaceuticals LLC | $45.94 | 2023 | Provenge |
| Takeda Pharmaceuticals U.S.A., INC. | $38.61 | 2023-2024 | Iclusig |
| Octapharma USA, INC. | $35.75 | 2022 | |
| Seagen INC. | $29.05 | 2022 | |
| Alexion Pharmaceuticals, INC. | $27.94 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $24.02 | 2023 | Monoferric |
| Conmed Corporation | $23.30 | 2025 | Visiclear |
| Kyowa Kirin, INC. | $22.09 | 2021 | |
| Amgen INC. | $14.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debbie Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.